Inhibition of Virulence Gene Expression in Staphylococcus Aureus by Novel Depsipeptides from a Marine Photobacterium
Overview
Pharmacology
Authors
Affiliations
During a global research expedition, more than five hundred marine bacterial strains capable of inhibiting the growth of pathogenic bacteria were collected. The purpose of the present study was to determine if these marine bacteria are also a source of compounds that interfere with the agr quorum sensing system that controls virulence gene expression in Staphylococcus aureus. Using a gene reporter fusion bioassay, we recorded agr interference as enhanced expression of spa, encoding Protein A, concomitantly with reduced expression of hla, encoding α-hemolysin, and rnaIII encoding RNAIII, the effector molecule of agr. A marine Photobacterium produced compounds interfering with agr in S. aureus strain 8325-4, and bioassay-guided fractionation of crude extracts led to the isolation of two novel cyclodepsipeptides, designated solonamide A and B. Northern blot analysis confirmed the agr interfering activity of pure solonamides in both S. aureus strain 8325-4 and the highly virulent, community-acquired strain USA300 (CA-MRSA). To our knowledge, this is the first report of inhibitors of the agr system by a marine bacterium.
Novel antibiotics against without detectable resistance by targeting proton motive force and FtsH.
Pengfei S, Yifan Y, Linhui L, Yimin L, Dan X, Shaowei G MedComm (2020). 2025; 6(1):e70046.
PMID: 39781293 PMC: 11707430. DOI: 10.1002/mco2.70046.
Inhibitory Effects of Lactobionic Acid on Biofilm Formation and Virulence of .
Kang S, Yang Y, Hou W, Zheng Y Foods. 2024; 13(17).
PMID: 39272546 PMC: 11395522. DOI: 10.3390/foods13172781.
Forssman and the staphylococcal hemolysins.
Ingmer H, Leisner J, Fulaz S APMIS. 2024; 133(1):e13459.
PMID: 39188243 PMC: 11669744. DOI: 10.1111/apm.13459.
Neuhaus G, Aron A, Isemonger E, Petras D, Waterworth S, Madonsela L PLoS One. 2024; 19(5):e0303273.
PMID: 38781236 PMC: 11115249. DOI: 10.1371/journal.pone.0303273.
Yamaguchi J, Manome T, Hara Y, Yamazaki Y, Nakamura Y, Ishibashi M Front Pharmacol. 2024; 15:1365815.
PMID: 38659576 PMC: 11039898. DOI: 10.3389/fphar.2024.1365815.